Cancer Immunology, Immunotherapy

, Volume 61, Issue 8, pp 1183–1190

FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer

  • Paul Salama
  • Colin Stewart
  • Cynthia Forrest
  • Cameron Platell
  • Barry Iacopetta
Original article


There are few clearly established prognostic factors available to guide the use of adjuvant chemotherapy in early stage colon cancer patients. Some of the most promising candidates include the invasion of extramural blood vessels by tumour cells and the densities of FOXP3+ T regulatory cells (Tregs) in tumour and adjacent normal colonic mucosal tissue. The aim of our study was to evaluate the prognostic significance of these markers in AJCC stage II colon cancer, with particular reference to lymphoid follicles in the mucosa. Histopathological review for the presence of vascular and serosal invasion was conducted on a series of 165 stage II colon cancers treated by surgery alone. Immunohistochemical staining for FOXP3 was performed on tumour tissue and histologically normal colonic mucosa from the surgical margin. Image analysis software was used to evaluate the density of FOXP3+ cells in the tumour core, invading margin and lymphoid follicles from the colonic mucosa. For survival analysis, cases were classified into high- or low-density of FOXP3+ cells according to the median value. The mean density of FOXP3+ Tregs in lymphoid follicles was twofold and fivefold higher than in the invading margin and tumour core, respectively. Multivariate analysis identified extramural vascular invasion (HR, 2.47; 95% CI: 1.00–6.07; P = 0.05) and high FOXP3+ cell density in lymphoid follicles (HR, 4.22; 95% CI: 1.49–11.91; P = 0.007) as independent factors for worse survival, whereas a high frequency of lymphoid follicles in histologically normal colonic mucosa was associated with better survival (HR, 0.31; 95% CI: 0.12–0.79; P = 0.014). Our data suggest that host factors related to the immune system have major prognostic significance in early stage colon cancer. The density of FOXP3+ cells within lymphoid follicles and the frequency of these structures in normal colonic mucosa represent novel and independent prognostic factors.


FOXP3 T regulatory cells Prognostic marker Lymphoid follicle Tumour-infiltrating lymphocytes Colorectal cancer 


  1. 1.
    Sobin LH, Wittekind C (1997) International union against cancer TNM classification of malignant tumours, 5th edn. Wiley, HobokenGoogle Scholar
  2. 2.
    Quirke P, Morris E (2007) Reporting colorectal cancer. Histopathology 50:103–112PubMedCrossRefGoogle Scholar
  3. 3.
    Williams GT, Quirke P, Shepherd NA (2007) Standards and datasets for reporting cancers. Dataset for colorectal cancer, 2nd edn. Royal College of Pathologists, LondonGoogle Scholar
  4. 4.
    Petersen VC, Baxter KJ, Love SB, Shepherd NA (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes’ B colon cancer. Gut 51:65–69PubMedCrossRefGoogle Scholar
  5. 5.
    Morris M, Platell C, de Boer B, McCaul K, Iacopetta B (2006) Population-based study of prognostic factors in stage II colonic cancer. Br J Surg 93:866–871PubMedCrossRefGoogle Scholar
  6. 6.
    Stewart CJ, Morris M, de Boer B, Iacopetta B (2007) Identification of serosal invasion and extramural venous invasion on review of Dukes’ stage B colonic carcinomas and correlation with survival. Histopathology 51:372–378PubMedCrossRefGoogle Scholar
  7. 7.
    Desolneux G, Burtin P, Lermite E, Bergamaschi R, Hamy A, Arnaud JP (2010) Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database. Int J Colorectal Dis 25:829–834PubMedCrossRefGoogle Scholar
  8. 8.
    Courtney ED, West NJ, Kaur C, Ho J, Kalber B, Hagger R, Finlayson C, Leicester RJ (2009) Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Dis 11:150–156PubMedCrossRefGoogle Scholar
  9. 9.
    Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494PubMedGoogle Scholar
  10. 10.
    Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318–324PubMedCrossRefGoogle Scholar
  11. 11.
    Prall F, Dührkop T, Weirich V, Ostwald C, Lenz P, Nizze H, Barten M (2004) Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 35:808–816PubMedCrossRefGoogle Scholar
  12. 12.
    Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K, Kurokawa Y, Satomi S (2004) Intraepithelial CD8+ T-cell-count become a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 91:1711–1717PubMedGoogle Scholar
  13. 13.
    Ohtani H (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 7:4PubMedGoogle Scholar
  14. 14.
    Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964PubMedCrossRefGoogle Scholar
  15. 15.
    Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654–2666PubMedCrossRefGoogle Scholar
  16. 16.
    Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A (2009) CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Lancet Oncol 10:877–884PubMedCrossRefGoogle Scholar
  17. 17.
    Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10:490–500PubMedCrossRefGoogle Scholar
  18. 18.
    Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192PubMedCrossRefGoogle Scholar
  19. 19.
    Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L (2010) High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126:2635–2643PubMedGoogle Scholar
  20. 20.
    Correale P, Rotundo MS, Del Vecchio MT, Remondo C, Migali C, Ginanneschi C, Tsang KY, Licchetta A, Mannucci S, Loiacono L, Tassone P, Francini G, Tagliaferri P (2010) Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother 33:435–441PubMedCrossRefGoogle Scholar
  21. 21.
    Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222:350–366PubMedCrossRefGoogle Scholar
  22. 22.
    Loddenkemper C, Schernus M, Noutsias M, Stein H, Thiel E, Nagorsen D (2006) In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med 4:52PubMedCrossRefGoogle Scholar
  23. 23.
    Ladoire S, Martin F, Ghiringhelli F (2011) Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60:909–918PubMedCrossRefGoogle Scholar
  24. 24.
    Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C (2011) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. doi:10.1002/cncr.26310. [Epub ahead of print]
  25. 25.
    Lee WS, Park S, Lee WY, Yun SH, Chun HK (2010) Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer. Cancer 116:5188–5199PubMedCrossRefGoogle Scholar
  26. 26.
    Langman JM, Rowland R (1986) The number and distribution of lymphoid follicles in the human large intestine. J Anat 149:189–194PubMedGoogle Scholar
  27. 27.
    Nascimbeni R, Di Fabio F, Di Betta E, Mariani P, Fisogni S, Villanacci V (2005) Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol 18:681–685PubMedCrossRefGoogle Scholar
  28. 28.
    Sipos F, Muzes G (2011) Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer? World J Gastroenterol 17:1666–1673PubMedCrossRefGoogle Scholar
  29. 29.
    Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, Lebecque S, Fridman WH, Cadranel J (2008) Long-term survival for patients with non-small-cell lung cancer with intra- tumoural lymphoid structures. J Clin Oncol 26:4410–4417PubMedCrossRefGoogle Scholar
  30. 30.
    Fu KI, Sano Y, Kato S, Fujii T, Koba I, Yoshino T, Ochiai A, Yoshida S, Fujimori T (2005) Incidence and localization of lymphoid follicles in early colorectal neoplasms. World J Gastroenterol 11:6863–6866PubMedGoogle Scholar
  31. 31.
    Lim HW, Hillsamer P, Banham AH, Kim CH (2005) Direct suppression of B cells by CD4 +CD25+ regulatory T cells. J Immunol 175:4180–4183PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Paul Salama
    • 1
  • Colin Stewart
    • 2
  • Cynthia Forrest
    • 3
  • Cameron Platell
    • 1
    • 4
  • Barry Iacopetta
    • 1
  1. 1.School of Surgery M507University of Western AustraliaNedlandsAustralia
  2. 2.Department of HistopathologyKing Edward Memorial HospitalSubiacoAustralia
  3. 3.Department of HistopathologyFremantle HospitalFremantleAustralia
  4. 4.Colorectal Cancer UnitSt John of God HospitalSubiacoAustralia

Personalised recommendations